Digital Therapeutics - United Kingdom

  • United Kingdom
  • Revenue in the Digital Therapeutics market is projected to reach US$202.40m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 27.79%, resulting in a projected market volume of US$539.80m by 2028.
  • User penetration will be 14.06% in 2024 and is expected to hit 30.31% by 2028.
  • The average revenue per user (ARPU) is expected to amount to US$20.86.
  • In global comparison, most revenue will be generated in the United States (US$3,147.00m in 2024).

Key regions: Japan, United States, India, France, United Kingdom

Region comparison

Analyst Opinion

The Digital Therapeutics market in United Kingdom is experiencing significant growth and development, driven by various factors influencing the demand for digital solutions in healthcare.

Customer preferences:
Customers in the United Kingdom are increasingly leaning towards digital therapeutics products due to their convenience, accessibility, and ability to provide personalized healthcare solutions. With the rising awareness about the importance of proactive healthcare management, patients are seeking digital tools that can help them monitor and manage chronic conditions such as diabetes, mental health disorders, cardiovascular issues, and musculoskeletal problems.

Trends in the market:
In the United Kingdom, there is a growing trend towards the integration of digital therapeutics into traditional healthcare systems. Healthcare providers are recognizing the potential of these digital solutions to improve patient outcomes, reduce healthcare costs, and enhance overall quality of care. This trend is further fueled by the increasing adoption of telemedicine and remote patient monitoring, especially in the wake of the COVID-19 pandemic. Moreover, partnerships between digital therapeutics companies and pharmaceutical firms are on the rise in the UK. These collaborations aim to combine the benefits of pharmaceutical interventions with digital tools to deliver comprehensive treatment solutions. Additionally, regulatory bodies in the UK are increasingly supportive of digital therapeutics, streamlining the approval process for these innovative products and paving the way for their widespread adoption.

Local special circumstances:
The National Health Service (NHS) in the United Kingdom plays a crucial role in shaping the digital therapeutics market. As one of the largest publicly funded healthcare systems in the world, the NHS has been actively exploring ways to integrate digital health technologies, including digital therapeutics, into its services. The endorsement and implementation of digital therapeutics by the NHS serve as a major driver for market growth in the UK. Furthermore, the UK has a strong ecosystem of digital health startups and innovators, fostering a culture of entrepreneurship and technological advancement in the healthcare sector. This vibrant landscape provides ample opportunities for collaboration, investment, and market expansion within the digital therapeutics industry.

Underlying macroeconomic factors:
The economic landscape of the United Kingdom, with its robust healthcare infrastructure, increasing healthcare expenditure, and supportive regulatory environment, creates a conducive market environment for the growth of digital therapeutics. The country's focus on innovation, research, and development further propels the market forward, attracting both domestic and international players to invest in digital healthcare solutions. Overall, the Digital Therapeutics market in the United Kingdom is poised for continued expansion and innovation, driven by evolving customer preferences, emerging market trends, local special circumstances, and favorable macroeconomic factors.


Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market market. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.


  • Revenue
  • Analyst Opinion
  • Users
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)